Y
Yuan Ma
Researcher at Shanghai Jiao Tong University
Publications - 29
Citations - 1258
Yuan Ma is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Chemistry & Drug delivery. The author has an hindex of 12, co-authored 24 publications receiving 697 citations. Previous affiliations of Yuan Ma include University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets.
TL;DR: This work re-port CRISPR-Cas12a sensors that are regulated by functional DNA (fDNA) molecules such as aptamers and DNAzymes that are selective for small organic molecule and metal ion detections that are suitable for field tests or point-of-care diagnostics.
Journal ArticleDOI
A Crosslinked Nucleic Acid Nanogel for Effective siRNA Delivery and Antitumor Therapy
Fei Ding,Quanbing Mou,Yuan Ma,Gaifang Pan,Yuanyuan Guo,Gangsheng Tong,Chung Hang Jonathan Choi,Xinyuan Zhu,Chuan Zhang +8 more
TL;DR: The crosslinked nanogels can assist the delivery of siRNAs into different cells without any transfection agents and achieve the gene silencing effectively both in’vitro and in vivo, through which a significant inhibition of tumor growth is realized in the anticancer treatment.
Journal ArticleDOI
A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
TL;DR: A novel targeting small molecule nanodrug self-delivery system consisting of targeting ligand and chemotherapy drug was constructed and showed excellent targeting ability and long blood circulation time with well-defined structure, high drug loading ratio and on-demand drug release behavior.
Journal ArticleDOI
DNA Trojan Horses: Self-Assembled Floxuridine-Containing DNA Polyhedra for Cancer Therapy
TL;DR: With precise control over the drug-loading ratio and structure of the nanocarriers, the DNA Trojan horse may play an important role in anticancer treatment and exhibit great potential in translational nanomedicine.
Journal ArticleDOI
Two-in-One Chemogene Assembled from Drug-Integrated Antisense Oligonucleotides To Reverse Chemoresistance.
TL;DR: A novel approach to synthesize a nanosized DDS using drug-integrated DNA with antisense sequences (termed "chemogene") to treat drug-resistant cancer is reported, which possesses the capabilities of rapid cell entry without the need for a transfection agent, efficient downregulation of drug resistance genes, and chronic release of chemotherapeutics for treating the drug- resistant tumors in both subcutaneous and orthotopic liver transplantation mouse models.